Discontinuation of Glucagon-Like Peptide-1 Receptor Agonists

Nov 16th 2024 5:50am EST

By Peter A. McCullough, MD, MPH It is remarkable to see formerly obese individuals undergo a miraculous slimming over several months on once weekly injections of glucagon-like peptide-1 receptor agonists. These drugs originally designed for type 2 diabetes, are associated with consistent weight loss, however, more muscle is lost than with conventional dieting. Khan et […]

Discuss on Nostr!

Nostr Note ID note1fcj8vsjlllenfk5e3j7eykh2d59s8kqt27f3pyl9xmt7mkpyg77qnukrxw Open on Primal.net Open on Snort.social Open on Iris.to Open on Coracle.social

New to Nostr?
Create an account now & join the conversation!

Promote it on DissentWatch!

  • To advertise this post for $0.02 per visit send bitcoins to the address below
  • The post will be promoted daily via social media & our "Featured News" display in multiple places
  • You can add more anytime
  • Ranking order in the Featured News box is based on the balance remaining


Received: 0 mBTC (0.00 USD)

Spent: 0 mBTC (0.00 USD)

Balance: 0 mBTC (0.00 USD)

The amounts above may be lagging behind. If you just sent a payment click below to get more up to date results and push the post to the "Featured News" box faster.

REFRESH AMOUNTS